Beyond Botox: Natural born killer or medical miracle?
Botox is best known for its use in cosmetic procedures, but this potent neurotoxin could be transformed into an extraordinary drug to treat a raft of debilitating conditions, a leading scientist will tell an audience at the University of Lincoln.
Synthesised by clostridium botulinum, botox is the most deadly poison known to man, however, in tiny doses it is widely used as an effective anti-aging treatment. In injection form the toxin blocks the signals that tell muscles to contract, reducing the appearance of wrinkles.
Now scientists are working to expand the toxin's potential as a prodigious drug that could be used for the treatment of disorders such as cerebral palsy, Parkinson's and chronic migraine.
A scientist from the University of Lincoln (UK), who is working on refining the botox protein, will talk about its use in treating a broad range of neurological disorders in a free public lecture on 19th March, 2013.
Dr Enrico Ferrari, from the University's School of Life Sciences, will also reveal the future avenues for turning this natural born killer into a therapeutic drug.
He said: "Many painkillers relieve pain temporarily and have various side effects. The selling point of this molecule is that the pain relief could last up to seven months, in a similar way that Botox injections last for several months. Engineering this kind of toxin has many uses and would be a major improvement in the quality of life for those people who suffer from chronic pain."
Dr Ferrari joined the University in October 2012 after spending three years working with a group at the Medical Research Council's Laboratory of Molecular Biology in Cambridge.
Led by Professor Bazbek Davletov, the team developed a new way of joining and rebuilding elements of the clostridium botulinum neurotoxin in a way that eliminated the unwanted toxic effects. In its natural state 150 nanograms would be enough to kill a person.
Dr Ferrari said: "The re-engineered toxin has very similar characteristics so is still able to block neurotransmission release, but the paralytic effect is a lot less because we have discovered a way to impede the toxin from reaching the muscles."
The lecture entitled Beyond Botox: molecular engineering and the design of new therapeutics takes place at 6pm on Tuesday, 19th March at the University of Lincoln's EMMTEC auditorium. Registration starts at 5.30pm.
A review paper entitled 'Presynaptic neurotoxins: An expanding array of natural and modified molecules' by Bazbek Davletov, Enrico Ferrari and Yuri Ushkaryov was published in the September/October 2012 edition of Cell Calcium.
More information: Go to www.sciencedirect.… 416012000942 to view the full paper.
Journal reference: Cell Calcium
Provided by University of Lincoln
- New insights about Botulinum toxin A Dec 02, 2010 | not rated yet | 0
- Don't let botox go to your head…or should you? Jan 08, 2013 | not rated yet | 0
- Australians trial Botox to treat hay fever Oct 09, 2012 | not rated yet | 0
- Study questions botox use for migraines Feb 08, 2011 | not rated yet | 0
- US approves Botox for bladder control Aug 24, 2011 | not rated yet | 0
- Motion perception revisited: High Phi effect challenges established motion perception assumptions Apr 23, 2013 | 3 / 5 (2) | 2
- Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update) Apr 02, 2013 | 4.5 / 5 (11) | 5
- The visual system as economist: Neural resource allocation in visual adaptation Mar 30, 2013 | 5 / 5 (2) | 9
- Separate lives: Neuronal and organismal lifespans decoupled Mar 27, 2013 | 4.9 / 5 (8) | 0
- Sizing things up: The evolutionary neurobiology of scale invariance Feb 28, 2013 | 4.8 / 5 (10) | 14
Why is zone 1 in liver more prone to ischemic injury?
May 23, 2013 Hi, Is it because around central vein, there is only deoxygenated blood from the vein where as in the periphery there is hepatic artery. Also why...
How can there be villous adenoma in colon, if there are no villi there
May 22, 2013 As title suggest. Thanks :smile:
How can there be a term called "intestinal metaplasia" of stomach
May 21, 2013 Hello everyone, Ok Stomach's normal epithelium is simple columnar, now in intestinal type of adenocarcinoma of stomach it undergoes "intestinal...
Pressure-volume curve: Elastic Recoil Pressure don't make sense
May 18, 2013 From pressure-volume curve of the lung and chest wall (attached photo), I don't understand why would the elastic recoil pressure of the lung is...
If you became brain-dead, would you want them to pull the plug?
May 17, 2013 I'd want the rest of me to stay alive. Sure it's a lousy way to live but it beats being all-the-way dead. Maybe if I make it 20 years they'll...
MRI bill question
May 15, 2013 Dear PFers, The hospital gave us a $12k bill for one MRI (head with contrast). The people I talked to at the hospital tell me that they do not...
- More from Physics Forums - Medical Sciences
More news stories
By discovering the new mechanism by which estrogen suppresses lipid synthesis in the liver, UC Irvine endocrinologists have revealed a potential new approach toward treating certain liver diseases.
Medical research May 23, 2013 | 5 / 5 (1) | 0 |
Aortic arch pulse wave velocity, a measure of arterial stiffness, is a strong independent predictor of disease of the vessels that supply blood to the brain, according to a new study published in the June issue the journal ...
Medical research May 23, 2013 | not rated yet | 0
Since the discovery of Prontosil in 1932, sulfonamide antibiotics have been used to combat a wide spectrum of bacterial infections, from acne to chlamydia and pneumonia. However, their side effects can include serious neurological ...
Medical research May 23, 2013 | 3 / 5 (1) | 0 |
Scientists at the National Institutes of Health report they have discovered in mouse studies that a small molecule released in the spinal cord triggers a process that is later experienced in the brain as ...
Medical research May 23, 2013 | 5 / 5 (3) | 0 |
Spanish researchers have discovered that the daily clearance of neutrophils from the body stimulates the release of hematopoietic stem cells from the bone marrow into the bloodstream, according to a report published today ...
Medical research May 23, 2013 | 5 / 5 (2) | 0
Heart failure accelerates the aging process and brings on early andropausal syndrome (AS), according to research presented today at the Heart Failure Congress 2013. AS, also referred to as male 'menopause', was four times ...
34 minutes ago | not rated yet | 0
Coenzyme Q10 decreases all cause mortality by half, according to the results of a multicentre randomised double blind trial presented today at Heart Failure 2013 congress. It is the first drug to improve heart failure mortality ...
40 minutes ago | not rated yet | 1
(AP)—Department of Justice lawyers have again asked a federal appeals court in New York to delay lifting age restrictions and prescription requirements on an emergency contraceptive popularly known as the morning-after ...
28 minutes ago | not rated yet | 0
Mortality and length of stay are highest in heart failure patients admitted in January, on Friday, and overnight, according to research presented today at the Heart Failure Congress 2013. The analysis of nearly 1 million ...
35 minutes ago | not rated yet | 0
(Medical Xpress)—A new study by researchers in the US has shown that an ancient virus can be modified to help in the fight against the simian immunodeficiency virus SIV, which is the equivalent in monkeys ...
22 hours ago | 5 / 5 (3) | 0 |
Two mutations central to the development of infantile myofibromatosis (IM)—a disorder characterized by multiple tumors involving the skin, bone, and soft tissue—may provide new therapeutic targets, according to researchers ...
16 hours ago | 3 / 5 (2) | 0 |